Chaince Digital Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CD research report →
Price Chart
About the company
Chaince Digital Holdings Inc. engages in providing financial and advisory services in the North America, Greater China, Southeast Asia, Hong Kong, Singapore, Malaysia, and the United States. The company offers industry advisory and consulting services, such as corporate restructuring, capital markets preparation, regulatory compliance, and business expansion strategies; IPO-related financial advisory and consulting services, including transaction structuring, preparation for regulatory filings, coordination with underwriters and professional advisors, and strategic capital markets advisory; and private investment in public equity advisory and placement-related services comprising identifying potential investors, assisting in transaction structuring, and coordinating the placement process.
- CEO
- Shi Qiu
- IPO
- 2015
- Employees
- 13
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on CD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $418.01M
- P/E
- -366.00
- PEG
- -3.66
- P/S
- 176.99
- P/B
- 4.63
- EV/EBITDA
- -225.52
- Div Yield
- 0.00%
- Gross Margin
- 70.89%
- Op Margin
- -72.16%
- Net Margin
- -23.46%
- ROE
- -0.98%
- ROIC
- -1.66%
Latest fiscal year · YoY change
- Revenue
- $1.87M+85.3%
- Gross Profit
- $1.20M+419.8%
- Op Income
- $-3,313,836
- Net Income
- $-5,097,831-12.4%
- EPS
- $-0.08-7.7%
- OCF Growth
- +21.3%
- FCF Growth
- +21.3%
- 52W High
- $14.10
- 52W Low
- $2.10
- 50D MA
- $6.14
- 200D MA
- $5.11
- Beta
- 8.12
- RSI (14)
- 37
- Avg Volume
- 309.26K
No earnings-call transcripts are available for CD yet.
- Free Float
- 74.7%
- Shares Outstanding
- 110.00M
- Float Shares
- 82.19M
of shares held by institutions
111 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Snow Lake Capital (Hk) Ltd | 4.20M | ▲ 400.00K |
| Etf Managers Group, LLC | 74.66K | ▲ 74.66K |
| Pictet Asset Management SA | 39.70K | ▲ 10.00K |
| Vident Investment Advisory, LLC | 13.44K | ▲ 13.44K |
| Beaumont Financial Partners, LLC | 13.43K | 0 |
Held by 86 ETFs
Biggest fund positions in CD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 24, 26 | McGillis Gregory | other | 0 |
| Aug 24, 26 | Li Jialin | other | 0 |
| May 19, 26 | Daye Wilfred ZhongKei | sell | 2,000 |
| May 20, 26 | Daye Wilfred ZhongKei | sell | 4,000 |
| May 21, 26 | Daye Wilfred ZhongKei | sell | 2,000 |
| Mar 18, 26 | Daye Wilfred ZhongKei | other | 0 |
| Mar 18, 26 | Zhang Yukuan | other | 0 |
| Mar 18, 26 | Nobel Sven Peter Emanuel | other | 0 |
| Mar 18, 26 | Cheng Hui | other | 0 |
| Mar 18, 26 | Qiu Shi | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CD coverage
Recent articles, reports, and earnings notes.
No research on CD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CD report →Chaince Digital Forms Chaince Compute to Pursue U.S. AI Data Center Development
globenewswire.com · Nov 19
Chaince Digital Reports Third Quarter 2026 Results: Revenue Up 92% Year-Over-Year, Shareholders' Equity at Highest Level in Nearly Eight Years
globenewswire.com · Nov 17
CD&R pursues buyout of $40 billion payments processor Global Payments, FT reports
reuters.com · Oct 30
Chaince Securities, LLC to Serve as Exclusive Sales Agent for Solowin Holdings' (NASDAQ: AXG) Up to US$50 Million At-the-Market Offering Program
globenewswire.com · Oct 27
U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease
gurufocus.com · Oct 23
Contrasting Chindata Group (NASDAQ:CD) & XP (NASDAQ:XP)
defenseworld.net · Oct 19
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
gurufocus.com · Oct 17
Chaince Securities, LLC to Serve as Exclusive Sales Agent for CL Workshop Group Limited's (NASDAQ: NWGL) Up to US$200 Million At-the-Market Offering Program
globenewswire.com · Oct 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.